13 Oct 2021 (Wed) – Morning Programme | Day 2 – Track 1
Keynote Address: Population Health Value-based Care from Vision to Reality | 9:00 – 9:40am
Ms. Holly Rimmasch, RN MSN, Chief Clinical Officer, Senior Vice President and General Manager,
Clinical Quality, Health Catalyst
Key Learning Highlights: Ms. Holly Rimmasch of Health Catalyst shared key insights into the value-based care approach for population health in the US, such as:
- Value-based care is about right sitting of care that emphasizes quality over quantity.
- The degree of care coordination, provider integration and accountability among healthcare ecosystem
entities are largely influenced by the types of health payment model adopted. She shared how the US
healthcare journey is moving from pay-per-service model to a capitation model.
- Population health management needs a data-informed, scaled infrastructure that is shared by all entities
within the healthcare ecosystem to facilitate a coordinated care plan.
- Population health management success can be measured with two metrics 1) population cost (payer
benchmark) or 2) member improvement (provider benchmark).
Track 1: Leverage Data & Tech for Population Health
Powering Breakthroughs in Behavioural Health | 9:45 – 10:15am
Mr. Nawal Roy, Founder and CEO, Holmusk
Key Learning Highlights: Mental health issues came into the spotlight during COVID-19 as more people
grapple with various life stressors. Mr. Nawal Roy of Holmusk shared current gaps in addressing mental
health issues globally (such as poor clinical standardisation for measurements and treatments due to
variations in symptoms, lack of quality data due to siloes among healthcare providers, lack of quantifiable
biomarkers and endpoints, social stigma, poor access to mental health care and so forth).
The company addressed the gaps by developing databases of real world evidence for behavioural health,
pioneering the use of unstructured data to derive symptoms, side effects, stressors and severity to
generate actionable insights for clinicians.
Unleashing Life-Changing Precision Medicines with Data | 10:30 – 11:00am
Mr. Jeffrey Lu, Co-Founder and CEO, Engine Biosciences
Key Learning Highlights: The availability of genomic data coupled with the power of AI allow prediction of
gene combinations that cause cancer cells and enable faster drug discovery and development. For
example, Mr. Jeffrey Lu’s Engine Biosciences’ algorithm has shown 10x increase in experimental efficiency
and high prediction accuracy for liver cancer. The company is continuously adding more new target-biomarker pairs to treat more types of cancers and may eventually extend to dermatology and other
diseases.
Getting good quality and diverse genomic dataset is critical for precision medicine. Singapore has the
unique advantage of a multi-ethnic population mix that is a good representation of Asia. Singapore made
public the genome sequencing of close to 5,000 Singaporeans in 2019 which opened up immense
opportunities for precision medicine and pharmaceutical companies to tap on. This is also an attraction
that led Engine Biosciences to set up its base here.
Epic’s Foundation and Strategies for Population-based Healthcare | 11:15 – 11:45am
Ms. Mallory Heinzeroth, Asia Pacific Regional Executive, Epic
Key Learning Highlights: The natural starting point to manage population health is typically the EMR,
since detailed patient data will be recorded during care interactions. The Epic team shared how healthcare
providers work together to create connected health grids between Epic and non-Epic institutions using
interoperability tools like Care Everywhere, Healthy Planet Link, FHIR APIs, and other standards-based
interfaces.
These tools enable providers to connect and share data beyond what they would have access to within
their own EMR system. Such integration provides richer data set for population health administrators to
use in establishing population health and value care model strategies.
Epic also showed how its platform can connect to services in the community, including home assistance
services, transportation assistance, food programs, child and family programs.
Enabling Corporates to Play an Active Role in Population Health with Technology and Data | 12:00 - 12:30pm
Ms. Rosaline Chow Koo, Founder and CEO, CXA Group
Key Learning Highlights: Ms. Rosaline Chow Koo from CXA group addressed population health from the
employer’s angle, where companies provide employees with a fixed budget benefits program that insured
them against workplace incidents and hefty hospitalisation bills. The programme also helps employees
and their family members to remain healthy with health screening packages, wellness and mental health
services offered by third parties.
Employers are motivated to come onboard this programme as it helps their employees stay healthy and
productive. Employeers can also personalise benefits and wellness based on their life stage and health
needs within the budget allocated. There is added convenience as the platform manages all the data and
payment flows between insurers, wellness and healthcare providers that simplify employer’s
administration.
Company-level insights and analysis also allow employers to design programmes to encourage employees
to take on a more active lifestyle such as launching department level sport challenges to nudge lasting
behavioural change.
Contact Us
For general enquiries, please contact the HealthTech X team at
ihis.healthtechx@ihis.com.sg
